Additionally, Huang et al. found that SF3B4 regulates HCC proliferation and apoptosis through alternative splicing and interactions with TRIM28 and SETD5, underscoring its potential as a therapeutic target for HCC (Huang et al., 2025). Here, SF3B4 is linked to hepatocellular carcinoma.